Access cutting-edge heart failure treatment through this clinical trial at a research site in Beverly Hills. Study-provided care at no cost to qualified participants.
Access heart failure specialists in Beverly Hills at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart failure treatment provided free
This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the study if they have been diagnosed with chronic HF at least 3 months before the study. The purpose of this study is to find out whether a medicine called vicadrostat, in combination with another medicine called empagliflozin, helps people with chronic heart failure. In this study, participants are put into 2 groups randomly. Participants
Sponsor: Boehringer Ingelheim
Check if you qualify for this heart failure clinical trial in Beverly Hills, CA
If you're searching for heart failure treatment options in Beverly Hills, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Beverly Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.